Olmesartan clinical trials
Includes 46 studies of Olmesartan Medoxomil.
How each study uses olmesartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the olmesartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Apr 2002 · BENICAR · NDA 021286 (FDA, Drugs@FDA; as Olmesartan Medoxomil)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
61 studies that test it; most in 2005 (14)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 14 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 40 · Other 24
Daiichi Sankyo (20) · Sankyo Pharma Gmbh (7) · Mylan Pharmaceuticals Inc (2) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (2) · Daiichi Sankyo Co., Ltd. (2) · EMS (2) · Tri-Service General Hospital (TSGH) (1) · Seoul National University Bundang Hospital (1)
Often tested with
Tested in the same studies.
Amlodipine (16) · Hydrochlorothiazide (13) · Losartan (5) · Dapagliflozin (2) · Rosuvastatin (2) · Irbesartan (2) · Valsartan (2) · Telmisartan (2)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses olmesartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 64
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as BenicarHow we know
- Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesRecruitingPhase 4Radboud University Medical CenterNCT05917275Written as OlmesartanHow we know
- A Single-center, Open-label, Non-randomized Pilot Study of add-on Olmesartan 20 mg or 40 mg Daily, With the Dose Chosen According to Blood Pressure at Enrollment as in Routine Practice, Over 9 Months in Patients With Type 2 Diabetes and Albuminuria Who Were Already Receiving an SGLT2i.CompletedNot applicableTri-Service General Hospital (TSGH)NCT07940790Written as OlmesartanHow we know
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnPhase 3EMSNCT02493322Written as Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mgHow we know
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnPhase 3EMSNCT02483936Written as Olmesartan medoxomil 40mg + chlorthalidone 12,5mgHow we know
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649623Written as Olmesartan Medoxomil Tablets 40 mgHow we know
- Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648219Written as Olmesartan Medoxomil Tablets 40 mgHow we know
- Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and HypertensionCompletedPhase 4Seoul National University Bundang HospitalNCT05189015Written as OlmesartanHow we know
- A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established AtherosclerosisCompletedPhase 3Daiichi SankyoNCT00382213Written as Olmesartan medoxomilHow we know
- Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult VolunteersCompletedPhase 1AutotelicbioNCT04856969Written as OlmesartanHow we know
- Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic StrokeCompletedPhase 2Aristotle University Of ThessalonikiNCT03655964Written as OlmesartanHow we know
- The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.CompletedPhase 1Pharmtechnology LLCNCT03951051Written as Olmesartan Medoxomil 40 mgHow we know
- Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TerminatedPhase 4Yonsei UniversityNCT02373462Written as OlmesartanHow we know
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedPhase 3Daiichi SankyoNCT00902538Written as Olmesartan medoxomil 40 mg - Amlodipine 10 mgHow we know
- Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedPhase 3Daiichi SankyoNCT00923091Written as olmesartan medoxomil + amlodipineHow we know
- Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCompletedPhase 3Daiichi SankyoNCT00649389Written as Olmesartan medoxomilHow we know
- A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedPhase 4Daiichi SankyoNCT00791258Written as amlodipine and olmesartan medoxomil tabletsHow we know
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedPhase 3Daiichi SankyoNCT00430508Written as olmesartan medoxomil/hydrochlorothiazide tabletsHow we know
- Amlodipine as add-on to Olmesartan in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220220Written as olmesartan medoxomilHow we know
- Olmesartan as an add-on to Amlodipine in HypertensionCompletedPhase 3Sankyo Pharma GmbhNCT00220233Written as olmesartan medoxomilHow we know
See all 64 studies that test olmesartan →
Given beside what is tested · 6 — olmesartan is usual care or a partner of the new treatment
- Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)CompletedPhase 2Alnylam PharmaceuticalsNCT05103332Written as OlmesartanHow we know
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as OlmesartanHow we know
- Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionCompletedPhase 3NovartisNCT00523744Written as Olmesartan medoxomilHow we know
- A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy VolunteersStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT02561884Written as Co-administration of Olmetec and CrestorHow we know
- Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)CompletedNot applicableKyoto University, Graduate School of MedicineNCT01028534Written as Olmesartan and AzelnidipineHow we know
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00696241Written as Azilsartan medoxomil and olmesartanHow we know
As the comparator · 20 — what is tested is compared with olmesartan
- Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX TabCompletedPhase 4Daewoong Pharmaceutical Co. LTD.NCT04120753Written as Olmesartan 20 mg/Amlodipine 5 mgHow we know
- A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With HypertensionCompletedPhase 2Novartis PharmaceuticalsNCT01870739Written as olmesartanHow we know
- Study of CS-3150 Compared to Olmesartan in Patients With Essential HypertensionCompletedNot applicableDaiichi Sankyo Co., Ltd.NCT02848170Written as olmesartan medoxomilHow we know
- Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedPhase 3Lee's Pharmaceutical LimitedNCT02609490Written as Olmesartan medoxomil tabletsHow we know
- Fimasartan Achieving SBP Target (FAST) StudyCompletedPhase 4Boryung Pharmaceutical Co., LtdNCT02495324Written as Olmesartan medoxomilHow we know
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01785472Written as OlmesartanHow we know
- Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionCompletedPhase 2Novartis PharmaceuticalsNCT01692301Written as OlmesartanHow we know
- Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to OlmesartanCompletedPhase 3Novartis PharmaceuticalsNCT01876368Written as OlmesartanHow we know
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01615198Written as OlmesartanHow we know
- Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential HypertensionCompletedPhase 3Novartis PharmaceuticalsNCT01599104Written as OlmesartanHow we know
- Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT02407210Written as Olmesartan medoxomilHow we know
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedPhase 3TakedaNCT01309828Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
- Clinical Study for Patients With Hypertension Associated With DyslipidemiaCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT01764295Written as OlmesartanHow we know
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00996281Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
- A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276CompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01493856Written as OlmetecHow we know
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedPhase 3TakedaNCT01033071Written as Olmesartan medoxomil and hydrochlorothiazideHow we know
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00696241Written as Azilsartan medoxomil and olmesartanHow we know
- An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedPhase 3TakedaNCT00696436Written as OlmesartanHow we know
- Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedPhase 2TakedaNCT00362115Written as OlmesartanHow we know
- Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedPhase 2TakedaNCT00759551Written as OlmesartanHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
Codes
What other systems call olmesartan · ClinicalTrials.gg INT004387
- MeSH (NLM) C437965olmesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 8W1IQP3U10OLMESARTANConfirmed FDA, NLM, Wikidata
- RxNorm 321064Confirmed FDA, Wikidata
- Wikidata Q421156olmesartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66253OlmesartanOne source FDA
- DrugBank DB00275One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C437965 | olmesartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 8W1IQP3U10 | OLMESARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 321064 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421156 | olmesartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66253 | Olmesartan | One source FDA |
| DrugBank | DB00275 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.